- Trials with a EudraCT protocol (8)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (8)
8 result(s) found for: MTA.
Displaying page 1 of 1.
EudraCT Number: 2004-002537-39 | Sponsor Protocol Number: H3E-IT-S079 | Start Date*: 2005-04-04 | |||||||||||
Sponsor Name:ELI LILLY | |||||||||||||
Full Title: Phase II Trial of Neoadjuvant ALIMTA plus Cisplatin followed by Surgery and Radiation in the Treatment of Pleural Mesothelioma | |||||||||||||
Medical condition: Plaural Mesothelioma | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2016-002474-13 | Sponsor Protocol Number: 3.199 | Start Date*: 2017-04-24 |
Sponsor Name:Innovatiefonds Zorgverzekeraars | ||
Full Title: Medication Optimization for ADHD: MOVA study Implementation and evaluation of double-blind placebo-controlled titration in clinical practice | ||
Medical condition: Attention Deficit Hyperactivity Disorder | ||
Disease: | ||
Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2012-001599-12 | Sponsor Protocol Number: 18F-AV-45-C01 | Start Date*: 2014-03-04 |
Sponsor Name:VU University Medical Center (VUmc) | ||
Full Title: The clinical value of amyloid imaging with [18F]-AV45 in a population of memory clinic patients | ||
Medical condition: The total number of inclusion in this study is 170 subjects; 140 patients (including Alzheimer’s disease (AD) patients, patients with mild cognitive impairment (MCI), patients with subjective memor... | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: NL (Prematurely Ended) | ||
Trial results: (No results available) |
EudraCT Number: 2023-000127-36 | Sponsor Protocol Number: KIH22001 | Start Date*: 2023-04-04 | |||||||||||
Sponsor Name:Karolinska Institutet | |||||||||||||
Full Title: Evaluating rapamycin treatment in Alzheimer’s disease using positron emission tomography (ERAP) | |||||||||||||
Medical condition: Alzheimer's disease (AD) and mild cognitive impairment (MCI) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: SE (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2018-004886-15 | Sponsor Protocol Number: MTA:CT4-09-18--Sponsor:18I-Fsg08 | Start Date*: 2019-05-17 | |||||||||||
Sponsor Name:IBSA INSTITUT BIOCHIMIQUE SA | |||||||||||||
Full Title: Evaluation of Treatment Satisfaction, Effectiveness and Tolerability in Subjects treated with Low-dose Diclofenac Epolamine Soft Capsules for Acute, Mild or Moderate Musculoskeletal Pain | |||||||||||||
Medical condition: Patients with acute, mild or moderate musculoskeletal pain | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2019-004987-23 | Sponsor Protocol Number: RAS-Triplet | Start Date*: 2020-05-22 |
Sponsor Name:UMC Utrecht | ||
Full Title: A Dose-Escalating Phase I/II Study in Patients with RAS-Mutated Metastatic Colorectal Cancer to Investigate Safety and Clinical Activity of the Triple Combination of: MEK-inhibitor binimetinib, Pan... | ||
Medical condition: colorectal cancer | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Trial now transitioned) | ||
Trial results: (No results available) |
EudraCT Number: 2020-001755-41 | Sponsor Protocol Number: GV971-007 | Start Date*: 2021-02-10 | |||||||||||
Sponsor Name:Green Valley (Shanghai) Pharmaceuticals Co., Ltd. | |||||||||||||
Full Title: A Phase 3, multi-center, randomized, double-blind, parallel-group, placebo-controlled clinical trial to evaluate the efficacy and safety of sodium oligomannate (GV-971) in treatment of mild to mode... | |||||||||||||
Medical condition: mild to moderate Alzheimer’s disease | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: CZ (Completed) DE (Prematurely Ended) FR (Prematurely Ended) PL (Prematurely Ended) NL (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2004-002425-52 | Sponsor Protocol Number: H3E-MC-JMEN(a) | Start Date*: 2005-03-24 | |||||||||||
Sponsor Name:Eli Lilly and Company Limited | |||||||||||||
Full Title: A Phase 3 Study of Pemetrexed Plus Best Supportive Care versus Best Supportive Care As Maintenance Therapy Immediately Following Induction Treatment For Advanced Non-Small Cell Lung Cancer | |||||||||||||
Medical condition: Non Small Cell Lung Cancer Stage IIIB or Stage IV | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) CZ (Completed) AT (Completed) HU (Completed) IT (Completed) ES (Completed) | |||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
